Cholesterol crystals in the pathogenesis of atherosclerosis

No abstract is available for this paper.

• Publication year

  2024

• Venue

  Nature Reviews Cardiology

• Publication date

  2024-11-18

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1038/s41569-024-01100-3PMID 39558130
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vascular smooth muscle cells in response to cholesterol crystals modulates inflammatory cytokines release and promotes neutrophil extracellular trap formation

  2024influential reference
• COLCHICINE REDUCES MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

  2024cited by this paper
• Thin-cap fibroatheroma in acute coronary syndrome: Implication for intravascular imaging assessment.

  2024cited by this paper
• The role of the NLRP3 inflammasome in atherosclerotic disease: Systematic review and meta-analysis.

  2024cited by this paper
• Cholesterol trafficking to the ER leads to the activation of CaMKII/JNK/NLRP3 and promotes atherosclerosis

  2024cited by this paper
• Low-dose colchicine for atherosclerosis: long-term safety.

  2024cited by this paper
• HDL Therapeutics - Time for a Curtain Call or Time to Reconceptualize?

  2024cited by this paper
• Different Characteristics and Interleukin-6 Ratios of Scattering-Type Aortic Plaques

  2024cited by this paper
• The effect of colchicine on cholesterol crystal formation, expansion and morphology: a potential mechanism in atherosclerosis

  2024cited by this paper
• Endothelial Cell-Derived Cholesterol Crystals Promote Endothelial Inflammation in Early Atherogenesis

  2024cited by this paper
• Cholesterol Crystal Dissolution Rate of Serum Predicts Outcomes in Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

  2024cited by this paper
• Pathophysiology and targeted treatment of cholesterol crystal embolism and the related thrombotic angiopathy

  2023cited by this paper
• Association of Life's Essential 8 With Cardiovascular Disease and Mortality: The Framingham Heart Study

  2023cited by this paper
• Low-Dose Colchicine for Secondary Prevention of Coronary Artery Disease: JACC Review Topic of the Week.

  2023cited by this paper
• High-Risk Plaques on Coronary Computed Tomography Angiography: Correlation With Optical Coherence Tomography.

  2023cited by this paper
• Associations between neighborhood socioeconomic deprivation, IFNγ, and high-density lipoprotein particle size: Data from the Washington, D.C. cardiovascular health and needs assessment.

  2023cited by this paper
• Cardiovascular Biomarkers: Current Status and Future Directions

  2023cited by this paper
• Lysosomal cholesterol overload in macrophages promotes liver fibrosis in a mouse model of NASH

  2023cited by this paper
• Statins utilization trends and expenditures in the U.S. before and after the implementation of the 2013 ACC/AHA guidelines

  2023influential reference
• Direct Observation of Uptake and Dissolution of Cholesterol Crystals by Macrophages Using Combined Fluorescence and X-ray Microscopy.

  2023cited by this paper
• Cholesterol crystals at the culprit lesion in patients with acute coronary syndrome are associated with worse cardiovascular outcomes at two years follow up - results from the translational OPTICO-ACS study program (R2).

  2023cited by this paper
• Sex Differences in Coronary Atherosclerotic Phenotype and Healing Pattern on Optical Coherence Tomography Imaging

  2023cited by this paper
• Association of coronary plaque morphology with inflammatory biomarkers and target lesion revascularization in patients with chronic coronary syndrome: an optical coherence tomography study.

  2023cited by this paper
• Biomimetic nanoparticles to enhance the reverse cholesterol transport for selectively inhibiting development into foam cell in atherosclerosis

  2023cited by this paper
• Cholesterol crystal formation is a unifying pathogenic mechanism in the development of diabetic retinopathy

  2023cited by this paper
• Social Determinants modulate NK cell activity via obesity, LDL, and DUSP1 signaling

  2023cited by this paper
• Macrophages mediate psoriasis via Mincle-dependent mechanism in mice

  2023cited by this paper
• Complosome — the intracellular complement system

  2023cited by this paper
• Fantastic voyage: The journey of NLRP3 inflammasome activation

  2023cited by this paper
• Inflammasome Signaling, Thromboinflammation, and Venous Thromboembolism

  2023cited by this paper
• Cholesterol crystals induce mechanical trauma, inflammation, and neo-vascularization in solid cancers as in atherosclerosis

  2023cited by this paper
• Circulating lipoprotein (a) and all-cause and cause-specific mortality: a systematic review and dose-response meta-analysis

  2023cited by this paper
• NLRP3 inflammasome in hepatic diseases: A pharmacological target.

  2023cited by this paper
• Pancoronary plaque characteristics and clinical outcomes in acute coronary syndrome patients with cancer history.

  2023cited by this paper
• OCT Emerging Technologies: Coronary Micro-optical Coherence Tomography.

  2023cited by this paper
• TFEB SUMOylation in macrophages accelerates atherosclerosis by promoting the formation of foam cells through inhibiting lysosomal activity

  2023cited by this paper
• Colchicine exerts anti‐atherosclerotic and ‑plaque‐stabilizing effects targeting foam cell formation

  2023cited by this paper
• Optical Coherence Tomography in Vulnerable Plaque and Acute Coronary Syndrome.

  2023cited by this paper
• Cytokines as Biomarkers for Evaluating Physical Exercise in Trained and Non-Trained Individuals: A Narrative Review

  2023cited by this paper
• From Innate Immunity to Metabolic Disorder: A Review of the NLRP3 Inflammasome in Diabetes Mellitus

  2023cited by this paper
• TFEB signaling attenuates NLRP3‐driven inflammatory responses in severe asthma

  2022cited by this paper
• Thin-Cap Fibroatheroma Rather Than Any Lipid Plaques Increases the Risk of Cardiovascular Events in Diabetic Patients: Insights From the COMBINE OCT–FFR Trial

  2022cited by this paper
• Atorvastatin Attenuates Diet-Induced Non-Alcoholic Steatohepatitis in APOE*3-Leiden Mice by Reducing Hepatic Inflammation

  2022cited by this paper
• Social Determinants of Cardiovascular Disease

  2022cited by this paper
• Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics

  2022cited by this paper
• Anchoring β-CD on simvastatin-loaded rHDL for selective cholesterol crystals dissolution and enhanced anti-inflammatory effects in macrophage/foam cells.

  2022influential reference
• The NLRP3 Inflammasome Pathway: A Review of Mechanisms and Inhibitors for the Treatment of Inflammatory Diseases

  2022cited by this paper
• Beneficial Effects of Three Dietary Cyclodextrins on Preventing Fat Accumulation and Remodeling Gut Microbiota in Mice Fed a High-Fat Diet

  2022cited by this paper
• Association of Lipoprotein(a) With Atherosclerotic Plaque Progression

  2022cited by this paper
• Lipophagy at a glance.

  2022cited by this paper
• Examining atherosclerotic lesions in three dimensions at the nanometer scale with cryo-FIB-SEM

  2022influential reference
• Cholesterol accumulation in macrophages drives NETosis in atherosclerotic plaques via IL-1β secretion

  2022cited by this paper
• The relationships between cholesterol crystals, NLRP3 inflammasome, and coronary atherosclerotic plaque vulnerability in acute coronary syndrome: An optical coherence tomography study

  2022influential reference
• Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association.

  2022cited by this paper
• Pregnancy-Induced Hypertension: The Potential Role of Cholesterol Crystals in the Maternal Decidua

  2022cited by this paper
• Chronic kidney disease and NLRP3 inflammasome: Pathogenesis, development and targeted therapeutic strategies

  2022cited by this paper
• Effect of aspirin on cholesterol crystallization: A potential mechanism for plaque stabilization

  2022cited by this paper
• Inflammasomes in Cancer Progression and Anti-Tumor Immunity

  2022cited by this paper
• Protective Effect of SIRT6 on Cholesterol Crystal-induced Endothelial Dysfunction via Regulating ACE2 Expression.

  2021cited by this paper
• Targeting Inflammatory Pathways in Cardiovascular Disease: The Inflammasome, Interleukin-1, Interleukin-6 and Beyond

  2021cited by this paper
• Formation and Cellular Impact of Cholesterol Crystals in Health and Disease.

  2021cited by this paper
• Importance of NLRP3 Inflammasome in Abdominal Aortic Aneurysms

  2021cited by this paper
• Effects of colchicine on major adverse cardiac events in next 6-month period after acute coronary syndrome occurrence; a randomized placebo-control trial

  2021cited by this paper
• Phospholipid nanoparticles: Therapeutic potentials against atherosclerosis via reducing cholesterol crystals and inhibiting inflammation

  2021influential reference
• Targeting the Inflammasome in Cardiovascular Disease

  2021cited by this paper
• Diagnosis, treatment, and follow-up of a case of Wolman disease with hemophagocytic lymphohistiocytosis

  2021cited by this paper
• Targeting lysosomes in human disease: from basic research to clinical applications

  2021cited by this paper
• Transcription factor EB regulates cardiovascular homeostasis.

  2021cited by this paper
• Mitochondrial C5aR1 activity in macrophages controls IL-1β production underlying sterile inflammation

  2021cited by this paper
• Non-linear optical imaging of atherosclerotic plaques in the context of SIV and HIV infection prominently detects crystalline cholesterol esters

  2021cited by this paper
• Lysosome (Dys)function in Atherosclerosis—A Big Weight on the Shoulders of a Small Organelle

  2021cited by this paper
• Neighborhood Environment Associates with Trimethylamine-N-Oxide (TMAO) as a Cardiovascular Risk Marker

  2021cited by this paper
• Targeting the NLRP3 inflammasome in cardiovascular diseases.

  2021cited by this paper
• Pharmacological targeting of NLRP3 deubiquitination for treatment of NLRP3-associated inflammatory diseases

  2021cited by this paper
• Targeting the NLRP3 Inflammasome as a New Therapeutic Option for Overcoming Cancer

  2021cited by this paper
• Pro-Inflammatory Implications of 2-Hydroxypropyl-β-cyclodextrin Treatment

  2021cited by this paper
• ABCA1 and ABCG1 as potential therapeutic targets for the prevention of atherosclerosis.

  2021cited by this paper
• Alterations in Lysosome Homeostasis in Lipid-Related Disorders: Impact on Metabolic Tissues and Immune Cells

  2021cited by this paper
• Vascular smooth muscle cells in atherosclerosis:Time for a reassessment.

  2021cited by this paper
• GCase and LIMP2 Abnormalities in the Liver of Niemann Pick Type C Mice

  2021cited by this paper
• Cholesterol crystal induced inflammation and mechanical cardiac valve injury: Implications for transcatheter aortic-valve replacement

  2021cited by this paper
• Dysfunctional Vascular Endothelium as a Driver of Atherosclerosis: Emerging Insights Into Pathogenesis and Treatment

  2021cited by this paper
• Cholesterol Crystals and NLRP3 Mediated Inflammation in the Uterine Wall Decidua in Normal and Preeclamptic Pregnancies

  2020cited by this paper
• Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

  2020cited by this paper
• Cyclodextrin related drug delivery system to promote atherosclerosis regression.

  2020cited by this paper
• Cholesterol crystals and atherosclerosis.

  2020cited by this paper
• Crystallization of Cholesterol in Phospholipid Membranes Follows Ostwald's Rule of Stages.

  2020cited by this paper
• Last step in the path of LDL cholesterol from lysosome to plasma membrane to ER is governed by phosphatidylserine

  2020cited by this paper
• Neutrophil Extracellular Traps Participate in Cardiovascular Diseases

  2020cited by this paper
• Targeting Lysosomes in Cancer as Promising Strategy to Overcome Chemoresistance—A Mini Review

  2020cited by this paper
• Lipoprotein(a): is it more, less or equal to LDL as a causal factor for cardiovascular disease and mortality?

  2020cited by this paper
• Sex-Specific Effects of the Nlrp3 Inflammasome on Atherogenesis in LDL Receptor-Deficient Mice

  2020cited by this paper
• Targeting the NLRP3 Inflammasome With Inhibitor MCC950 Prevents Aortic Aneurysms and Dissections in Mice

  2020cited by this paper
• Lysosomal Acid Lipase Deficiency

  2020cited by this paper
• Dissolving cholesterol crystals reduces aortic valve stenosis development in mice

  2020cited by this paper
• Hyperlipidaemia and IFNgamma/TNFalpha Synergism are associated with cholesterol crystal formation in Endothelial cells partly through modulation of Lysosomal pH and Cholesterol homeostasis

  2020influential reference
• Repair or Lysophagy: Dealing with Damaged Lysosomes.

  2020cited by this paper
• Viewing atherosclerosis through a crystal lens: How the evolving structure of cholesterol crystals in atherosclerotic plaque alters its stability.

  2020cited by this paper
• Cyclodextrins: Potential therapeutics against atherosclerosis.

  2020cited by this paper
• Cardiovascular Disease in Nonalcoholic Steatohepatitis: Screening and Management

  2020influential reference

• HDL in Abdominal Aortic Aneurysm: Mechanistic Insight and Therapeutic Potential

  2026cites this paper
• Progress in the Cross-Organ Biomarker oxLDL in Promoting Pathological Neovascular Diseases.

  2026cites this paper
• Retinal phenotype of APOB100 transgenic mice on a Western diet with human-like hyperlipidemia and cholesterol crystals in the retina and choroid

  2026cites this paper
• Targeting the Gut-Liver-Heart Axis: Role of Bacterial TMA Lyase and Human FMO-3 in Atherosclerosis and Dietary Interventions

  2026cites this paper
• Emerging regulators of endothelial lipid metabolism in atherosclerosis.

  2026cites this paper
• Cholesterol-Inflammation Fusion Hypothesis in Atherosclerosis: An Evolving Paradigm in Pathogenesis and Therapy.

  2026cites this paper
• Lipid-laden macrophages in atherosclerosis and cancer.

  2025cites this paper
• Phospholipid metabolism in innate immunity and inflammation: from basic to clinic

  2025cites this paper
• Zwitterionic Supramolecular Nanoassemblies With siRNA and Simvastatin as "Nanoscavenger" for Synergistic Atherosclerosis Treatment.

  2025cites this paper
• APOE4 promotes nigral tau hyperphosphorylation through cholesterol in atherosclerosis

  2025cites this paper
• Reconceptualizing Endothelial-to-mesenchymal transition in atherosclerosis: Signaling pathways and prospective targeting strategies

  2025cites this paper
• NLRP3 inhibition by VTX3232 tempers inflammation resulting in reduced body weight, hyperglycemia, and hepatic steatosis in obese male mice

  2025cites this paper
• Isolinderalactone attenuates atherosclerosis through inhibiting NF-κB-mediated inflammation in macrophages.

  2025cites this paper
• Multi-trait association analysis reveals shared genetic architecture between lung cancer and cardiometabolic diseases

  2025cites this paper
• In Situ Reprogramming of Senescent Microenvironment via Augmentation of Endogenous Senolytic Actions for Advanced Atherosclerosis Management.

  2025cites this paper
• State-of-the-art wearable sensors for cardiovascular health: a review

  2025cites this paper
• Gut microbiota-derived metabolites: Potential targets for cardiorenal syndrome.

  2025cites this paper
• Cyclodextrin‐Derived Macromolecular Therapies for Inflammatory Diseases

  2025cites this paper
• Targeting cholesterol-driven pyroptosis: a promising strategy for the prevention and treatment of atherosclerosis

  2025cites this paper
• Cholesterol Crystals as Triggers of NLRP3 Inflammasome Activation in Atherosclerosis

  2025cites this paper
• Identification and Management Strategies for Intracoronary High Thrombus Burden in Patients With STEMI: A Practical Experience and Literature Review

  2025cites this paper